Klin Monbl Augenheilkd 2017; 234(04): 508-514
DOI: 10.1055/s-0043-100230
Kasuistik
Georg Thieme Verlag KG Stuttgart · New York

Torpedo Maculopathy Associated with Choroidal Neovascularization

Torpedo-Makulopathie mit choroidaler Neovaskularisation
D. Jurjevic
1   Department of Ophthalmology, University Hospital Zurich, Zurich, Switzerland (Chairman: Prof. Dr. med. Klara Landau)
,
C. Böni
1   Department of Ophthalmology, University Hospital Zurich, Zurich, Switzerland (Chairman: Prof. Dr. med. Klara Landau)
,
D. Barthelmes
1   Department of Ophthalmology, University Hospital Zurich, Zurich, Switzerland (Chairman: Prof. Dr. med. Klara Landau)
,
K. Fasler
1   Department of Ophthalmology, University Hospital Zurich, Zurich, Switzerland (Chairman: Prof. Dr. med. Klara Landau)
,
M. Becker
2   Department of Ophthalmology, Triemli Hospital, Zurich, Switzerland (Chairman: Prof. Dr. med. Matthias Becker)
,
S. Michels
2   Department of Ophthalmology, Triemli Hospital, Zurich, Switzerland (Chairman: Prof. Dr. med. Matthias Becker)
,
J. Stemmle
3   Augenarztpraxis Stemmle, Zurich, Switzerland
,
C. Herbort
4   Inflammatory and Retinal Eye Diseases, Centre for Ophthalmic Specialized Care, Montchoisi Teaching Centre, Lausanne, Switzerland
,
S. A. Zweifel
1   Department of Ophthalmology, University Hospital Zurich, Zurich, Switzerland (Chairman: Prof. Dr. med. Klara Landau)
› Author Affiliations
Further Information

Publication History

Publication Date:
03 May 2017 (online)

Abstract

Background Torpedo maculopathy is a very rare, congenital, usually unilateral hypopigmented lesion in the temporal macula.

Material and Methods This retrospective case series describes three patients with torpedo maculopathy.

Results The first two cases demonstrate typical clinical and imaging findings of torpedo maculopathy in asymptomatic patients. The third case relates to a symptomatic young patient with a torpedo lesion, a smaller satellite lesion, and evidence of choroidal neovascularization confirmed by fluorescence angiography. In the area of the clinically visible torpedo lesion, spectral domain optical coherence tomography showed atrophy of the outer retina with increased choroidal signalling and a hyperreflective lesion above the retinal pigment epithelium suggestive of choroidal neovascularization. Fundus autofluorescence imaging revealed a hyperautofluorescent rim along the margin of the hypoautofluorescent torpedo lesion.

Conclusion In the literature, torpedo lesions are usually regarded as benign lesions with no tendency for progression. The third case demonstrates that torpedo lesions may be associated with choroidal neovascularization, which has been successfully treated with anti-VEGF therapy.

Zusammenfassung

Hintergrund Bei der Torpedo-Makulopathie handelt es sich um eine seltene, angeborene hypopigmentierte Läsion der temporalen Makula.

Material und Methoden Diese retrospektive Fallserie beschreibt 3 Patienten mit Torpedo-Makulopathie.

Ergebnisse In 2 Fällen handelt es sich um ophthalmologische Zufallsbefunde bei asymptomatischen Patienten. Im 3. Fall geht es um eine symptomatische Patientin mit einer Torpedo-Läsion, einer kleinen Satellitenläsion und einer aktiven choroidalen Neovaskularisation, bestätigt mittels Fluoreszenzangiografie. Die optische Kohärenztomografie beim 3. Fall zeigt eine hyporeflektive Läsion mit Alteration des retinalen Pigmentepithels und typischen Veränderungen im Rahmen der choroidalen Neovaskularisationen. In der Autofluoreszenzaufnahme präsentiert sich eine hypoautofluoreszente Torpedo-Läsion mit einem schmalen hyperautofluoreszenten Randsaum.

Schlussfolgerung In der Literatur gilt die Torpedo-Makulopathie weitestgehend als benigne Läsion ohne Tendenz zur Progression. Der 3. Fall beschreibt die Assoziation einer Torpedo-Makulopathie mit einer choroidalen Neovaskularisation. Erfreulicherweise führte eine wiederholte Anti-VEGF-Therapie zu einer vollständigen Remission der choroidalen Neovaskularisationen mit Visuserholung.

 
  • References

  • 1 Daily M. Torpedo Maculopathy or paramacular Spot Syndrome. Chicago: New Dimensions in Retina Symposium; 1993: 11
  • 2 Teitelbaum BA, Hachey DL, Messner LV. Torpedo maculopathy. J Am Optom Assoc 1997; 68: 373-376
  • 3 Shields CL, Guzman JM, Shapiro MJ. et al. Torpedo maculopathy at the site of the fetal „bulge“. Arch Ophthalmol 2010; 128: 499-501
  • 4 Golchet PR, Jampol LM, Mathura jr. JR. et al. Torpedo maculopathy. Br J Ophthalmol 2010; 94: 302-306
  • 5 Sanabria MR, Coco RM, Sanchidrian M. OCT findings in torpedo maculopathy. Retin Cases Brief Rep 2008; 2: 109-111
  • 6 Rohl A, Vance S. Hyperpigmented torpedo maculopathy with pseudo-lacuna: a 5-year follow-up. Case Rep Ophthalmol 2016; 7: 184-190
  • 7 Wong EN, Fraser-Bell S, Hunyor AP. et al. Novel optical coherence tomography classification of torpedo maculopathy. Clin Exp Ophthalmol 2015; 43: 342-348
  • 8 Agarwal A. Gassʼ Atlas of macular Diseases. Toronto, Canada: Elsevier Health Sciences; 2011: 1076
  • 9 Thomas AS, Flaxel CJ, Pennesi ME. Spectral-domain optical coherence tomography and fundus autofluorescence evaluation of torpedo maculopathy. J Pediatr Ophthalmol Strab 2015; 52: E8-E10
  • 10 Trevino R, Kiani S, Raveendranathan P. The expanding clinical spectrum of torpedo maculopathy. Optometry Vis Sci 2014; 91: S71-S78
  • 11 Marmorstein AD, Finnemann SC, Bonilha VL. et al. Morphogenesis of the retinal pigment epithelium: toward understanding retinal degenerative diseases. Ann N Y Acad Sci 1998; 857: 1-12
  • 12 Beatty S, Koh H, Phil M. et al. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 2000; 45: 115-134
  • 13 Wyszynski RE, Grossniklaus HE, Frank KE. Indirect choroidal rupture secondary to blunt ocular trauma: a review of eight eyes. Retina 1988; 8: 237-243